Invited Commentary: Cardiocel ® Patch: A Biological Tissue for Cardiac Repair,Not a Bioscaffold. Best Indications in Congenital Heart Surgery

Abstract

Get full access to this article

View all access options for this article.

References

Patukale

Suna

Anand

, et al. Performance of CardioCel in cardiac surgery: a systematic review. World J Pediatr Congenit Heart Surg. In press.

Salameh

Greimann

Vondrys

Kostelka

. Calcification or not. This is the question. A 1-year study of bovine pericardial vascular patches (CardioCel) in minipigs. Semin Thorac Cardiovasc Surg. 2018;30(1):54-59.

Pavy

Michielon

Robertus

Lacour-Gayet

Ghez

. Initial 2-year results of CardioCel^® patch implantation in children. Interact Cardiovasc Thorac Surg. 2018;26(3):448-453.

Bell

Prabhu

Betts

, et al. Durability of tissue-engineered bovine pericardium (CardioCel^®) for a minimum of 24 months when used for the repair of congenital heart defects. Interact Cardiovasc Thorac Surg. 2019;28(2):284-290.

Chivers

Pavy

Vaja

Quarto

Ghez

Daubeney

PEF

. The Ozaki procedure with CardioCel patch for children and young adults with aortic valve disease: preliminary experience—a word of caution. World J Pediatr Congenit Heart Surg. 2019;10(6):724-730.

Nordmeyer

Murin

Schulz

, et al. Results of aortic valve repair using decellularized bovine pericardium in congenital surgery. Eur J Cardiothorac Surg. 2018;54(6):986-992.

Tomšič

Bissessar

van Brakel

Marsan

Klautz

RJM

Palmen

. Initial experience and early results of mitral valve repair with CardioCel pericardial patch. Ann Thorac Surg. 2018;106(4):1241-1244.